New research shows the shingles vaccine may reduce dementia risk by 20%. A unique UK rollout offers compelling, bias-resistant data supporting the link.

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A cardiologist shares insights on the findings.

I was surprised to hear the nurse practitioner say that a new shingles vaccine was available. The Food and Drug Administration had approved Shingrix (zoster vaccine recombinant) in 2017 as a more ...

A CDC committee voted to recommend a new shingles vaccine for Americans 50 and older because it’s more effective than the current vaccine.

The Food and Drug Administration (FDA) has accepted for review the regulatory application for a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).. Shingrix ...

The vaccine, which has been available in the European Union since 2018 for individuals aged 50 and older and since 2020 for those 18 and older at increased risk of herpes zoster, is a non-live ...